Main content

    Autism Clinical Trials

    Sutter Health participates in clinical trials related to Autism throughout their Northern California facilities. See the listing below for an overview of current trials, including contact information. For some trials, more detailed information can be found via the title link to ClinicalTrials.gov.

    Title: A Randomized, Placebo-Controlled, Blinded, Crossover, Single-Center Study of the Effects of Nuedexta in the Treatment of Neurobehavioral Symptoms of Adults with Autism Spectrum Disorder (Protocol CHKI-Nued0911.
    Description: Demonstrate reduced frequency and intensity of maladaptive behaviors as measured by the Aberrant Behavior Checklist (ABC) Irritability subscale in subjects given Nuedexta 8 weeks over subjects given placebo.
    Secondary: Demonstrate a trend towards reduced aggressive behavior as measured by Overt Aggression Scale (OAS).
    Investigator: Michael Chez, MD
    Eligibility: Adults 18 to 50 years of age. Diagnosis of Autistic Spectrum Disorder based on DSM-IV-TR criteria, developmental history, and ADOS; or confirmed diagnosis of autism during childhood through similar methods. Mood issues and frontal lobe type perseveration issues.
    Status: Active and open to enrollment.
    Location: Sutter Medical Center, Sacramento
    Contact: Bobbie Benabides, CRC 916-454-6924 Email: Benabib@sutterhealth.org


    Title: A Randomized, Blinded, Placebo-Controlled, Crossover Study to Assess the Efficacy of Stem Cells from Autologous Umbilical Cord Blood to Improve Language and Behavior in Children with Autism (Protocol CB2011Chez).
    Description:  A randomized, blinded, placebo-controlled, crossover study to assess the efficacy of stem cells from autologous umbilical cord blood to improve language and behavior in children with autism.
    Investigator: Michael Chez, MD
    Eligibility: Children.
    Status: Active and open to enrollment
    Location: Sutter Medical Center, Sacramento
    Contact: Linh Dang-Chu, CRC,
    (916) 733-4482, Email: DangAL1@sutterhealth.org

    Title: Streptococcal Antibodies in Autism Spectrum Disorders with Catatonia
    Description: Collecting data in patients with neurodevelopmental disorders  presenting with a PANDAS-like syndrome.
    Investigator: Shawn Kile, MD
    Eligibility:
    Status:Active and open to enrollment.Location: Sutter Medical Center, Sacramento
    Contact: Tammy Donnel, CRC 916-453-5994, Email: Donnelt@sutterhealth.org


    > See All Neurology Clinical Trials by Condition